David D Stenehjem - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

David D Stenehjem

Showing results (21-30 of 45) with videos related to

Pageof 5

Sort By:

Pharmacy Practice|September 14, 2020

Pharmacist's attitudes and knowledge of pharmacogenomics and the factors that may predict future engagementMegan E Hundertmark, Stephen C Waring, David D Stenehjem, et al.

Clinical Lung Cancer|November 14, 2020

Real-World Effectiveness of Nivolumab Monotherapy After Prior Systemic Therapy in Advanced Non-Small-Cell Lung Cancer in the United StatesDavid D Stenehjem, Solomon J Lubinga, Komal Gupte-Singh, et al.

Breast Cancer (Dove Medical Press)|November 8, 2014

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancerDavid D Stenehjem, Minkyoung Yoo, Sudhir K Unni, et al.

Oncotarget|November 26, 2019

Tumor mutational burden in lung cancer: a systematic literature reviewConnor Willis, Michelle Fiander, Dao Tran, et al.

Archives of Dermatological Research|May 9, 2018

Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record reviewVanessa W Stevens, David D Stenehjem, Olga V Patterson, et al.

Journal of Ovarian Research|March 24, 2016

BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort studySudhir K Unni, Marisa B Schauerhamer, Rishi Deka, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2021

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?Eman Biltaji, Brandon Walker, Trang H Au, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014

Response monitoring, tolerability, and effectiveness of imatinib treatment for chronic myeloid leukemia in a retrospective research databaseDavid D Stenehjem, Frederick Albright, Kuan-Ling Kuo, et al.

Clinical Genitourinary Cancer|January 20, 2016

Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic TherapiesShiven B Patel, David D Stenehjem, David M Gill, et al.

Cancer Research Communications|March 24, 2026

Real-world characterization and treatment patterns of patients with desmoid tumors at an academic center in the United StatesChia Jie Tan, Connor Willis, Timothy Bell, et al.

Pageof 5

Search research articles

Showing results (21-30 of 45) with videos related to

Sort By:

Pageof 5

Pharmacy Practice|September 14, 2020

Pharmacist's attitudes and knowledge of pharmacogenomics and the factors that may predict future engagementMegan E Hundertmark, Stephen C Waring, David D Stenehjem, et al.

Clinical Lung Cancer|November 14, 2020

Breast Cancer (Dove Medical Press)|November 8, 2014

Assessment of HER2 testing patterns, HER2+ disease, and the utilization of HER2-directed therapy in early breast cancerDavid D Stenehjem, Minkyoung Yoo, Sudhir K Unni, et al.

Oncotarget|November 26, 2019

Tumor mutational burden in lung cancer: a systematic literature reviewConnor Willis, Michelle Fiander, Dao Tran, et al.

Archives of Dermatological Research|May 9, 2018

Journal of Ovarian Research|March 24, 2016

BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort studySudhir K Unni, Marisa B Schauerhamer, Rishi Deka, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 14, 2021

Can Cost-effectiveness Analysis Inform Genotype-Guided Aspirin Use for Primary Colorectal Cancer Prevention?Eman Biltaji, Brandon Walker, Trang H Au, et al.

Journal of the National Comprehensive Cancer Network : JNCCN|August 8, 2014

Clinical Genitourinary Cancer|January 20, 2016

Everolimus Versus Temsirolimus in Metastatic Renal Cell Carcinoma After Progression With Previous Systemic TherapiesShiven B Patel, David D Stenehjem, David M Gill, et al.

Cancer Research Communications|March 24, 2026

Real-world characterization and treatment patterns of patients with desmoid tumors at an academic center in the United StatesChia Jie Tan, Connor Willis, Timothy Bell, et al.

Pageof 5